Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Bucolo

Showing results (81-90 of 201) with videos related to

Pageof 21
Sort By:
Journal of Cellular Physiology|February 17, 2019
Curcumin prevents high glucose damage in retinal pigment epithelial cells through ERK1/2-mediated activation of the Nrf2/HO-1 pathwayClaudio Bucolo, Filippo Drago, Rosa Maisto, et al.
Current Pharmaceutical Design|September 10, 2015
Controversies in Glaucoma: Current Medical Treatment and Drug DevelopmentClaudio Bucolo, Chiara Bianca Maria Platania, Michele Reibaldi, et al.
Current Neuropharmacology|September 20, 2017
Novel Therapeutics in Glaucoma ManagementClaudio Bucolo, Chiara Bianca Maria Platania, Filippo Drago, et al.
Biochemical Pharmacology|August 18, 2020
P2X7 receptor antagonism preserves retinal ganglion cells in glaucomatous miceGiovanni Luca Romano, Rosario Amato, Francesca Lazzara, et al.
Plos One|May 9, 2014
Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trialsGiuseppe Grosso, Andrzej Pajak, Stefano Marventano, et al.
Pharmaceuticals (Basel, Switzerland)|October 26, 2024
The Identification of New Pharmacological Targets for the Treatment of Glaucoma: A Network Pharmacology ApproachErika Giuffrida, Chiara Bianca Maria Platania, Francesca Lazzara, et al.
Pharmacological Research|July 19, 2015
Nrf2 activators modulate oxidative stress responses and bioenergetic profiles of human retinal epithelial cells cultured in normal or high glucose conditionsRoberta Foresti, Claudio Bucolo, Chiara Maria Bianca Platania, et al.
European Journal of Pharmacology|April 4, 2006
A novel adamantane derivative attenuates retinal ischemia-reperfusion damage in the rat retina through sigma1 receptorsClaudio Bucolo, Agostino Marrazzo, Simone Ronsisvalle, et al.
Frontiers in Pharmacology|October 20, 2017
Buspirone Counteracts MK-801-Induced Schizophrenia-Like Phenotypes through Dopamine D<sub>3</sub> Receptor BlockadeSebastiano Alfio Torrisi, Salvatore Salomone, Federica Geraci, et al.
International Journal of Molecular Sciences|December 18, 2020
Novel Heme Oxygenase-1 (HO-1) Inducers Based on Dimethyl Fumarate StructureValeria Sorrenti, Luca Vanella, Chiara Bianca Maria Platania, et al.
Pageof 21

Showing results (81-90 of 201) with videos related to

Sort By:
Pageof 21
Journal of Cellular Physiology|February 17, 2019
Curcumin prevents high glucose damage in retinal pigment epithelial cells through ERK1/2-mediated activation of the Nrf2/HO-1 pathwayClaudio Bucolo, Filippo Drago, Rosa Maisto, et al.
Current Pharmaceutical Design|September 10, 2015
Controversies in Glaucoma: Current Medical Treatment and Drug DevelopmentClaudio Bucolo, Chiara Bianca Maria Platania, Michele Reibaldi, et al.
Current Neuropharmacology|September 20, 2017
Novel Therapeutics in Glaucoma ManagementClaudio Bucolo, Chiara Bianca Maria Platania, Filippo Drago, et al.
Biochemical Pharmacology|August 18, 2020
P2X7 receptor antagonism preserves retinal ganglion cells in glaucomatous miceGiovanni Luca Romano, Rosario Amato, Francesca Lazzara, et al.
Plos One|May 9, 2014
Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trialsGiuseppe Grosso, Andrzej Pajak, Stefano Marventano, et al.
Pharmaceuticals (Basel, Switzerland)|October 26, 2024
The Identification of New Pharmacological Targets for the Treatment of Glaucoma: A Network Pharmacology ApproachErika Giuffrida, Chiara Bianca Maria Platania, Francesca Lazzara, et al.
Pharmacological Research|July 19, 2015
Nrf2 activators modulate oxidative stress responses and bioenergetic profiles of human retinal epithelial cells cultured in normal or high glucose conditionsRoberta Foresti, Claudio Bucolo, Chiara Maria Bianca Platania, et al.
European Journal of Pharmacology|April 4, 2006
A novel adamantane derivative attenuates retinal ischemia-reperfusion damage in the rat retina through sigma1 receptorsClaudio Bucolo, Agostino Marrazzo, Simone Ronsisvalle, et al.
Frontiers in Pharmacology|October 20, 2017
Buspirone Counteracts MK-801-Induced Schizophrenia-Like Phenotypes through Dopamine D<sub>3</sub> Receptor BlockadeSebastiano Alfio Torrisi, Salvatore Salomone, Federica Geraci, et al.
International Journal of Molecular Sciences|December 18, 2020
Novel Heme Oxygenase-1 (HO-1) Inducers Based on Dimethyl Fumarate StructureValeria Sorrenti, Luca Vanella, Chiara Bianca Maria Platania, et al.
Pageof 21